These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Viral antibody titers. Comparison in patients with multiple sclerosis and rheumatoid arthritis. Shirodaria PV; Haire M; Fleming E; Merrett JD; Hawkins SA; Roberts SD Arch Neurol; 1987 Dec; 44(12):1237-41. PubMed ID: 2823754 [TBL] [Abstract][Full Text] [Related]
47. Complement-fixing activity of rheumatoid synovial fluid. Townes AS; Marcus RL Ann Rheum Dis; 1972 Sep; 31(5):393-401. PubMed ID: 5071634 [No Abstract] [Full Text] [Related]
48. The heterogeneity of serologic findings and predisposing host factors in drug-induced lupus erythematosus. Hughes GR; Rynes RI; Gharavi A; Ryan PF; Sewell J; Mansilla R Arthritis Rheum; 1981 Aug; 24(8):1070-3. PubMed ID: 6974553 [No Abstract] [Full Text] [Related]
49. Altered immune response to glycine-rich sequences of Epstein-Barr nuclear antigen-1 in patients with rheumatoid arthritis and systemic lupus erythematosus. Petersen J; Rhodes G; Roudier J; Vaughan JH Arthritis Rheum; 1990 Jul; 33(7):993-1000. PubMed ID: 2164400 [TBL] [Abstract][Full Text] [Related]
50. Incidence of antibodies to double-stranded RNA in systemic lupus erythematosus and related diseases. Schur PH; Stollar BD; Steinberg AD; Talal N Arthritis Rheum; 1971; 14(3):342-7. PubMed ID: 4998028 [No Abstract] [Full Text] [Related]
51. [Comparative study and importance of 3 technics for research of anti-DNA antibdoies. (Immunofluorescence on the Trypanosoma gambieuse nucleus, complement fixation, test conditioned hemagglutination)]. Monier JC; Thivolet J; Sepetjian M Ann Inst Pasteur (Paris); 1968 Sep; 115(3):403-15. PubMed ID: 4886013 [No Abstract] [Full Text] [Related]
52. Proceedings: A simple immunofluorescence method for differentiation of ANF between RA and healthy persons and SLE and scleroderma patients. Stojan B Ann Rheum Dis; 1975 Apr; 34(2):197-8. PubMed ID: 1094966 [No Abstract] [Full Text] [Related]
53. Virus antibodies and multiple sclerosis. Sever JL; Kurtzke JF; Alter M; Schumacher GA; Gilkeson MR; Ellenberg JH; Brody JA Arch Neurol; 1971 Jun; 24(6):489-94. PubMed ID: 4326199 [No Abstract] [Full Text] [Related]
54. [Study of DNA-binding activity of blood serum in systemic lupus erythematosus, rheumatoid arthritis and crossing syndromes]. Matveĭkov GP; Podgorodnichenko VK; Koshelev VK; Nazarov IuM Ter Arkh; 1976; 48(11):36-40. PubMed ID: 1021891 [No Abstract] [Full Text] [Related]
55. Correlation between the presence of antibodies to the Epstein-Barr virus nuclear antigen type 2 and antibodies to the rheumatoid arthritis nuclear antigen in patients with rheumatoid arthritis. Sculley TB; Pope JH; Hazelton RA Arthritis Rheum; 1986 Aug; 29(8):964-70. PubMed ID: 3017369 [TBL] [Abstract][Full Text] [Related]
56. The multifactorial etiology of rheumatic diseases. Barnett EV J Rheumatol; 1975 Jun; 2(2):125-9. PubMed ID: 1097681 [No Abstract] [Full Text] [Related]
58. Immune complexes and other laboratory features of pleural effusions: a comparison of rheumatoid arthritis, systemic lupus erythematosus, and other diseases. Halla JT; Schrohenloher RE; Volanakis JE Ann Intern Med; 1980 Jun; 92(6):748-52. PubMed ID: 7387017 [TBL] [Abstract][Full Text] [Related]
59. [Inhibiting action of chloroquine and para-aminobenzoic acid on the agglutinating activity of the rheumatoid factor]. CHIEREGATO G; TOSO M Minerva Dermatol; 1961 Dec; 36():454-7. PubMed ID: 13878939 [No Abstract] [Full Text] [Related]
60. Rheumatoid factor and antinuclear antibody in systemic lupus erythematosus, rheumatoid arthritis and infectious mononucleosis. Ichida CK; Yokoyama M Hawaii Med J; 1971; 30(3):170-3. PubMed ID: 4105320 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]